Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 °C

Clinical Chemistry

Volumn 52, Issue 2, 2006, Pages 235-239

  Ulmert, David ^a   Becker, Charlotte ^a   Nilsson, Jan Åke ^a   Piironen, Timo ^b   Björk, Thomas ^a   Hugosson, Jonas ^c   Berglund, Göran ^a   Lilja, Hans ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b Bayer Oy   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CALCULATION; CANCER SCREENING; CLINICAL OBSERVATION; CONCENTRATION RESPONSE; DIAGNOSTIC ACCURACY; FROZEN SECTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PLASMA; PROSTATE CANCER; PROTEIN DEGRADATION; REPRODUCIBILITY; SERUM; STATISTICAL SIGNIFICANCE; SWEDEN; SYSTEMATIC ERROR; TISSUE PRESERVATION;

EID: 31844447749     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.050641     Document Type: Article

References (18)

1. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery: what we have learned and where we are going. J Urol 1999;162:293-306.
2. Papsidero LD, Kuriyama M, Wang MC, Horoszewicz J, Leong SS, Valenzuela L, et al. Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 1981;66:37-42.
3. Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH, et al. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. Prostate 2005;63:13-8.
4. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
5. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, et al. Prostate-specific antigen in serum occurs predominantly.in complex with α1-antichymotrypsin. Clin Chem 1991;37:1618-25.
6. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett ATK, et al. Serum prostate-specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-5.
7. Luderer AA, Chen YT, Soriano TE, Kramp WJ, Carlson G, Cuny C, et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-94.
8. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate-specific antigen and its complex with α(1)-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994;344:1594-8.
9. Kessler B, Albertsen P. The natural history of prostate cancer. Urol Clin North Am 2003;30:219-26.
10. Pettersson K, Piironen T, Seppala M, Liukkonen L, Christensson A, Matikainen MT, et al. Free and complexed prostate-specific antigen (PSA): in-vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-α(1)- antichymotrypsin complex. Clin Chem 1995;41:1480-8.
11. Leinonen J, Stenman UH. Reduced stability of prostate-specific antigen after long-term storage of serum at -20 degrees C. Tumour Biol 2000;21:46-53.
12. Piironen T, Pettersson K, Suonpaa M, Stenman UH, Oesterling JE, Lovgren T, et al. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α(1)-antichymotrypsin in blood samples. Urology 1996;48:81-7.
13. Woodrum D, French C, Shamel LB. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology 1996;48(6A Suppl):33-9.
14. Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lovgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem 1995;41:1115-20.
15. Allard WJ, Zhou Z, Yeung KK. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 1998;44:1216-23.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
17. Woodrum D, York L. Two-year stability of free and total PSA in frozen serum samples. Urology 1998;52:247-51.
18. Hugosson J, Aus G, Bergdahl S, Fernlund P, Prosing R, Lodding P, et al. Population-based screening for prostate cancer by measuring free and total serum prostate specific antigen in Sweden. BJU Int 2003;92:39-43.